Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team…
Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team…
Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team…